Incident Dementia clinical trials

Explore recruiting incident dementia clinical trials.

Recruiting incident dementia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Incident Dementia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, placebo controlled, observer-blind, phase IV pragmatic trial to evaluate the effect of Recombinant Zoster Vaccine (Shingrix®) on incident dementia diagnosis in an older adult population aged ≥76 years in Finland

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Incident Dementia trials by city

Incident Dementia in Toronto Incident Dementia in Vancouver Incident Dementia in Montreal Incident Dementia in Calgary Incident Dementia in Edmonton Incident Dementia in Ottawa Incident Dementia in Winnipeg Incident Dementia in Quebec City Incident Dementia in Hamilton Incident Dementia in Kitchener Incident Dementia in London Incident Dementia in Halifax Incident Dementia in New York Incident Dementia in Los Angeles Incident Dementia in Chicago Incident Dementia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease